04:08 PM EST - Afexa Life Sciences Inc. : announced that its Board of Directors confirmed its previous recommendation that Afexa shareholders accept the offer by 1625907 Alberta Ltd. ("Acquireco"), a subsidiary of Valeant Pharmaceuticals International, Inc. ("Valeant"), pursuant to which Acquireco has agreed to acquire all of the outstanding common shares of Afexa for $0.71 per share in cash. Afexa Life Sciences Inc.
shares T.FXA are trading even at $0.73.
